Propranolol as a Novel Treatment for Congenital Visceral Haemangioma.

Autor:	Vanlander, Arnaud, Decaluwe, Wim, Vandelanotte, Michel, Van Geet, Christel, Cornette, Luc
Předmět:	PROPRANOLOL HEMANGIOMAS VISCERA blood-vessels GENETIC disorders SOFT tissue tumors INFANT disease treatment ADRENOCORTICAL hormones INTERFERONS THERAPEUTICS
Zdroj:	Neonatology (16617800); Sep2010, Vol. 98 Issue 3, p229-231, 3p
Abstrakt:	AbstractHaemangiomas are the most common soft tissue tumours in infancy, occurring in approximately 5–10 of 1-year-old children. Current drug-based therapeutic options for large haemangiomas include corticosteroids, α-interferon and vincristin, all of which can result in harmful side effects. Recently, promising results have been reported using the non-cardio-selective β-blocker propranolol for the treatment of cutaneous capillary haemangiomas, in which a spectacular size reduction was observed during the first 7 days of treatment. We here report a similar significant and rapid inhibitory effect of propranolol on the growth of a viscerally located congenital haemangioma.Copyright © 2010 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu